SCHEMBL29133795

SCHEMBL29133795

CCC1(Nc2ncnc3ccc(-c4cccc(-c5n[nH]c(=O)o5)c4)cc23)C=CC=CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 12/20 0.40
▸ MAP4K4 O95819 2/20 0.38
▸ CLK4 Q9HAZ1 4/20 0.36
▸ EGFR P00533 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ USP2 O75604 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HIF1A Q16665 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133782 0.83 EGFR (0.52) NOTUMEGFRPIK3CAPRKDC
SCHEMBL29133723 0.79 MAP4K4 (0.39) MAP4K4CLK4MEN1USP2ALDH1A1
SCHEMBL29133728 0.76 IRAK4 (0.48) MAP4K4CLK4EGFRMEN1USP2
SCHEMBL29133742 0.76 IRAK4 (0.35) MAP4K4CLK4PIK3CAMEN1USP2
SCHEMBL29133743 0.76 PIK3CA (0.53) MAP4K4CLK4PIK3CAMEN1USP2
SCHEMBL29133739 0.74 HTT (0.50) MEN1ALDH1A1LMNACYP1A2CYP3A4
SCHEMBL29133745 0.74 HTT (0.50) MEN1ALDH1A1LMNACYP1A2CYP3A4
SCHEMBL29133774 0.74 IRAK4 (0.47) MAP4K4CLK4EGFRPIK3CAMEN1
SCHEMBL29133752 0.73 HTT (0.36) MAP4K4CLK4EGFRLMNAMAPT
SCHEMBL29133735 0.73 HTT (0.36) MAP4K4CLK4EGFRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback